Keywords: Fertility preservation; leukemia; MRD; OTCP; ovarian tissue auto-transplantation;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: AML; acute myeloid leukemia; CH; clonal hematopoiesis; CHIP; clonal hematopoiesis of indeterminate potential; FDA; Food and Drug Administration; MDS; myelodysplastic syndrome; MGUS; monoclonal gammopathy of undetermined significance; MRD; minimal residual
Keywords: CV; coefficient of variation; CWC; capillary water content; DB; depth to bedrock; FWC; free water content; ITS; index of temporal stability; MAI; mean active index; MRD; mean relative difference; PLC; plane curvature; PRC; profile curvature; PTFs; pedotra
Keywords: Biotherapeutics; Gene and cell therapy; Pharmacokinetics; Non-clinical safety; Immunogenicity; Cross-reactive species; ATMP; advanced therapy medicinal products; CAR; chimeric antigen receptor; CD; cluster of differentiation; CMC; chemistry manufacturing
Keywords: CTA; Multiple Myeloma; Immunotherapy; MRD; Cyclins; Cascade;
Keywords: Circulating multiple myeloma cells; MRD; Clonal evolution; Next-generation sequencing;
Keywords: AIHA; autoimmune hemolytic anemia; B2M; β2-microglobulin; BR; bendamustine and rituximab; BTK; Bruton tyrosine kinase; CLL; chronic lymphocytic leukemia; CR; complete remission; FCR; fludarabine; cyclophosphamide; and rituximab; FISH; fluorescence in sit
Keywords: ALO; agricultural land occupation; APCR; air pollution control residues; BA; bottom ash; CC; climate change; CHP; combined heat and power; FA; fly ash; FD; fossil fuel depletion; FE; freshwater eutrophication; FET; freshwater ecotoxicity; FGT; flue gas tr
Keywords: Adaptive sliding mode control; Fuzzy sliding mode control; Magneto-rheological damper (MRD); MRD train-car suspension; Optimal fuzzy disturbance observer; MRD; magneto-rheological damper; i-MRD; inverse MRD; UAD; uncertainty and disturbance; SMC; sliding
Keywords: Microenvironment; MRD; Plasticity; Proliferation; Quiescence;
Keywords: Acute myeloid leukemia; AML; Response criteria; Minimal residual disease; MRD; Clinical trials;
Keywords: Ocular graft-versus-host disease; Dry eye disease; Hematopoietic stem cell transplantation; Allo-HSCT; allogeneic hematological stem cell transplantation; BCVA; best corrected visual acuity; CsA; cyclosporin A; DED; dry eye disease; GVHD; graft-versus-hos
Keywords: B-CLPD; B-cell chronic lymphoproliferative disorders; BM; bone marrow; CONT; contaminated group; FCM; flow-cytometry; GC; good-quality group; MGUS; Monoclonal gammopathy of undetermined significance; MM; Multiple myeloma; MRD; minimal residual disease; PB
Keywords: Acute myeloid leukemia; AML; Autologous transplant; Complete remission; CR; Hematopoietic cell transplantation; HCT; Minimal residual disease; MRD;
Keywords: ABC; advanced breast cancer; CGH; comparative genomic hybridization; CNA; copy number alterations; CTC; circulating tumor cells; ctDNA; cell-free tumor DNA; DEP; dielectrophoretic; DFS; disease-free survival; dPCR; digital PCR; EBC; early breast cancer; E
Keywords: Plug flow; Slug flow; Transition; Flow visualization; Local measurement; FPS; Frame Per Second; TPFTR; Two Phase Flow Test Rig; LDV; Laser Doppler Velocimetry; MRD; Mean Relative Deviation;
Keywords: MRD; Eyebrow position; Ptosis; Upper eyelid; Correlation; Hering's law;
Keywords: Plasma cell dyscrasia; Plasma cell neoplasm; Multiparametric flow cytometry; Multiple myeloma; Minimal residual disease; MRD; Panel optimization; High-sensitivity assay;
Keywords: Acute lymphoblastic leukemia; ALL; Allogeneic; Cytogenetics; Dasatinib; Imatinib; Minimal residual disease; MRD; Nilotinib; Philadelphia chromosome positive; Ph+; Ponatinib; Stem cell transplant; TKI; Tyrosine kinase inhibitor;
Keywords: AD; Alzheimer's disease; CTB-HRP; cholera toxin subunit B-horseradish peroxidase; CeA; central amygdaloid nucleus; MrD; the marginal division of the striatum; TMB; 3,3â²,5,5â²Tetramethylbenzidine; Basal ganglia; c-Fos protein; Immunohistochemistry; Tr
Keywords: MSD; MesoScale Discovery; ECL; electrochemiluminescence; ACE; affinity capture elution; ADA; anti-drug antibody; TAb; therapeutic antibody; MRD; minimum require dilution; TMB; 3,3â²,5,5â² tetramethylbenzidine; HRP; horseradish peroxidase; NHS; normal hu
Keywords: AA; accelerated approval; ALL; acute lymphoblastic leukemia; CCyR; complete cytogenetic response; CLL; chronic lymphocytic lymphoma; CML; chronic myeloid leukemia; CRC; colorectal carcinoma; CR; complete response; CRi; complete response with incomplete bl
Keywords: ASCT; autologous stem cell transplant; EMD; extramedullary disease; FLC; free light chain; ISS; International Staging System; KRD; carfilzomib, lenalidomide, and dexamethasone; MGUS; monoclonal gammopathy of undetermined significance; MM; multiple myeloma
Keywords: AE; adverse event; ALL; acute lymphoblastic leukemia; alloSCT; allogeneic hematopoietic stem cell transplant; AYA; adolescent and young adult; BFM; Berlin-Frankfurt-Münster; CAR-T; chimeric antigen receptor-modified T cell; CCyR; complete cytogenetic r
Keywords: Mantle cell; Stem cell transplantation; Maintenance; MRD; Novel therapies; Bortezomib; Ibrutinib; Lenalidomide;
Keywords: Cancer stem cell; Chemotherapy; Chemoresistance; Targeted therapy; 5-FU; 5-fluorouracil; ABCT; ATP-binding cassette transporter; ALDH; Aldehyde dehydrogenase; AML; Acute myeloid leukemia; ASC; Adult stem cell; BCRP or ABCG; Breast cancer resistance protei
Keywords: MRD; Margin reflex distance;
Case ReportA novel cryptic CBFB-MYH11 gene fusion present at birth leading to acute myeloid leukemia and allowing molecular monitoring for minimal residual disease
Keywords: AML; CBFB-MYH11 fusion gene; Cytogenetics; RT-PCR; MRD; Neonatal blood spot;
Combination of cabazitaxel and plicamycin induces cell death in drug resistant B-cell acute lymphoblastic leukemia
Keywords: ALL; acute lymphoblastic leukemia; BM; bone marrow; MRD; minimal residual disease; CAB; cabazitaxel; PLI; plicamycin; NP; nanoparticles; PD; phase dim; B-cell acute lymphoblastic leukemia; Bone marrow microenvironment; Minimal residual disease; Drug resis
MRD Testing in Multiple Myeloma: From a Surrogate Marker of Clinical Outcomes to an Every-Day Clinical Tool
Keywords: MRD; multiple myeloma; survival; treatment;
ETV6/RUNX1-positive childhood acute lymphoblastic leukemia (ALL): The spectrum of clonal heterogeneity and its impact on prognosis
Keywords: ETV6/RUNX1-positive ALL; Childhood leukemia; FISH; ETV6/RUNX1 fusion gene; Cytogenetics; ALL; acute lymphoblastic leukemia; EFS; event-free survival; OS; overall survival; RFS; relapse-free survival; BM; bone marrow; SUB; subclones; mSUB; minor subclones;
Dynamic regulation of six histone H3 lysine (K) methyltransferases in response to prolonged anoxia exposure in a freshwater turtle
Keywords: K; lysine; R; arginine; H3K4me1; monomethylated histone H3 lysine 4; H3K27me1; monomethylated histone H3 lysine 27; H3K9me3; trimethylated histone H3 lysine 9; HP1; heterochromatin protein 1; HKMT; histone lysine methyltransferases; SAM; S-adenosyl-L-meth
Bispecific antibodies for cancer therapy: A review
Keywords: ADCC; antibody-dependent cell-mediated cytotoxicity; AE; adverse events; ALL; acute lymphoblastic leukemia; ALP; alkaline phosphatase; ALT; alanine aminotransferase; AST; aspartate aminotransferase; B-ALL; B-cell acute lymphoblastic leukemia; BiTES; Bi-sp
Reformation in chimeric antigen receptor based cancer immunotherapy: Redirecting natural killer cell
Keywords: NK cell; natural killer cell; IFN-γ; interferon-γ; IL; interleukin; TNF-α; tumor necrosis factor-α; CCL; C-C motif ligand; GM-CSF; granulocyte-macrophage colony-stimulating factor; ADCC; antibody dependent cell-mediated cytotoxicity; TRAIL; TNF-relate
Do cytogenetics affect the post-remission strategy for older patients with AML in CR1?
Keywords: Acute myeloid leukemia; Age; AML; Azacitidine; Clofarabine; Consolidation; CPX-351; Cytarabine; Cytogenetics; Daunorubicin; Decitabine; Minimal residual disease; MRD; Reduced intensity conditioning; RIC; Risk; TP53; Transplant;
Development and validation of an ELISA method for the quantification of nivolumab in plasma from non-small-cell lung cancer patients
Keywords: ALP; Alkaline Phosphatase; ALT; alanine transaminase; AST; aspartate aminotransferase; BSA; Bovine Serum Albumin; CRP; C-Reactive Protein; CV; Coefficient of Variation; ECOG; Eastern Cooperative Oncology Group; EMA; European Medicines Agency; FDA; Food an
Acute Promyelocytic Leukemia: A Perspective
Keywords: APL; ATO; ATRA; Cure; MRD;
Original ArticlesInfluence of Musculoskeletal Manifestations as the Only Presenting Symptom in B-Cell Acute Lymphoblastic Leukemia
Keywords: children; symptom duration; limb pain; overall survival; ALL; Acute lymphoblastic leukemia; B-ALL; B-cell type acute lymphoblastic leukemia; HR; Hazard ratio; MRD; Minimal residual disease; NCI; National Cancer Institute; WBC; White blood cell;
The efficacy of different cleaning and disinfection procedures to reduce Salmonella and Enterobacteriaceae in the lairage environment of a pig abattoir
Keywords: AMR; antimicrobial resistance; BG; brilliant green; BPW; buffered peptone water; CFU; colony forming unit; LB; luria-bertani; LOD; limit of detection; MIC; minimal inhibitory concentration; MRD; maximum recovery diluent; MSRV; modified semi-solid rapport-
SOHO Supplement 2017Minimal Residual Disease Assessment and Risk-based Therapy in Acute Lymphoblastic Leukemia
Keywords: ALL; Management; MRD; Prognosis; Risk classification;
Pharmacogenomics in acute lymphoblastic leukemia
Keywords: Pharmacogenomics; Acute; Lymphoblastic; Leukemia; ALL; Response; MRD; Toxicity;
Hematologic neoplasms: Dendritic cells vaccines in motion
Keywords: DCs; dendritic cells; TAA; tumor-associated antigens; APC; antigen presenting cells; mDCs; myeloid dendritic cells; pDCs; plasmacytoid dendritic cells; HLA; human leukocyte antigen; Ag Antigens; abs antibodies; PBMCs; peripheral blood mononuclear cells; G
AML in 2017: Advances in clinical practice
Keywords: Acute myeloid leukemia; AML; Hedgehog; Histone deacetylase; IDH; Minimal residual disease; MRD; Transplant;
Chimeric antigen receptor T-cells for B-cell malignancies
Keywords: ALL; acute lymphoblastic leukemia; B-ALL; B-cell acute lymphoblastic leukemia; CAR-T; chimeric antigen receptor T-cell; CAR; chimeric antigen receptor; CD; cluster of differentiation; CHOP; Children's Hospital of Philadelphia; CLL; chronic lymphocytic leu
Regulation of pyruvate dehydrogenase (PDH) in the hibernating ground squirrel, (Ictidomys tridecemlineatus)
Keywords: PDH; Pyruvate dehydrogenase; PDHK; Pyruvate dehydrogenase kinases; PDP; Pyruvate dehydrogenase phosphatases; MRD; Metabolic rate depression; RPP; Reversible protein phosphorylation; TCA; Tricarboxylic acid cycle; F-2; 6-P2, Fructose 2,6-bisphosphate; PFK;
MAP kinase signaling and Elk1 transcriptional activity in hibernating thirteen-lined ground squirrels
Keywords: ATF2; activating transcription factor 2; bZIP; basic leucine zipper; Ca2Â +; Â calcium; CREB; cAMP-responsive element binding protein; DPI-ELISA; DNA-protein interaction enzyme-linked immunosorbent assay; EA; early arousal; EC; euthermic control; Elk1; ET
Is there justification for 4 cycles of consolidation therapy in AML?
Keywords: Acute myeloid leukemia; AML; CBF; Consolidation; Core binding factor; Genetic landscape; Minimal residual disease; MRD; Mutation status; NPM1; Nucleophosmin 1;
AML in 2016: Where we are now?
Keywords: Acute leukemia forum; Acute lymphoblastic leukemia; Acute myeloid leukemia; ALL; AML; Blinatumomab; Genomics; IDH; Minimal residual disease; MRD;
Immunophenotypic Characterization of Cytogenetic Subgroups in Egyptian Pediatric Patients With B-Cell Acute Lymphoblastic Leukemia
Keywords: ALL; CD123; CD200; CD79b; Hyperdiploidy; MRD;